Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
7503826 | Drug and Alcohol Dependence | 2016 | 8 Pages |
Abstract
After 40 years of injection-based naloxone treatment, non-injectable routes are finally being developed. Nasal naloxone has recently been approved and will soon be field-tested, buccal naloxone holds promise, and it is unclear what sublingual naloxone will contribute. Development and approval of reliable non-injectable formulations will facilitate wider naloxone provision across the community internationally.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
John Strang, Rebecca McDonald, Abdulmalik Alqurshi, Paul Royall, David Taylor, Ben Forbes,